Bill

Bill > S2137


MA S2137

MA S2137
Relative to HIV-associated lipodystrophy syndrome treatment


summary

Introduced
02/18/2016
In Committee
07/30/2016
Crossed Over
07/31/2016
Passed
07/31/2016
Dead
Signed/Enacted/Adopted
08/10/2016

Introduced Session

189th General Court

Bill Summary

Relative to HIV-Associated lipodystrophy treatment (Senate, No. 618),-- reports, recommending that the same ought to pass with an amendment substituting a new draft with the same title (Senate, No. 2137).

AI Summary

This bill mandates that various health insurance providers, including the state's medical assistance program (referred to as "the division"), accident and sickness insurance policies, employee health and welfare funds, hospital service plans, medical service agreements, and health maintenance organizations, must cover medical and drug treatments for disturbances in body composition caused by HIV-associated lipodystrophy syndrome. These treatments can include reconstructive surgery like liposuction, other restorative procedures, and dermal injections or fillers to address facial fat loss, provided a treating physician confirms the necessity of the treatment for the condition. Crucially, these benefits cannot be subject to higher deductibles, coinsurance, copayments, or out-of-pocket limits than other benefits offered by the respective insurer.

Committee Categories

Budget and Finance

Sponsors (0)

No sponsors listed

Other Sponsors (1)

Senate Committee on Ways and Means (Senate)

Last Action

Signed by the Governor, Chapter 233 of the Acts of 2016 (on 08/10/2016)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...